News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
Enrique Soto: Great attendance at the Geriatric Oncology session in MASCC2025
Enrique Soto/X
Jun 30, 2025, 16:43

Enrique Soto: Great attendance at the Geriatric Oncology session in MASCC2025

Enrique Soto, Geriatric oncologist and Editor-in-Chief of ecancer’s journal, shared a post on X:

“Great attendance at the Geriatric Oncology session in MASCC2025 to learn about loneliness in older adults with cancer!”

Enrique Soto geriatric oncology

More posts featuring Enrique Soto on OncoDaily.

cancer Enrique Soto Geriatric Oncology GeriOnc MASCC25 OncoDaily Oncology
Special Coverage
Blog
Jun 30, 2025, 16:43
Enrique Soto: Great attendance at the Geriatric Oncology session in MASCC2025
Science
Jun 30, 2025, 16:39
ESGO Shared an Article on Peritonectomy Procedures for Peritoneal Surface Malignancies
Blog
Jun 30, 2025, 16:33
Nina Niu Sanford: New GI pathology 101 series With Suntrea Hammer - Coming Soon
Blog
Jun 30, 2025, 16:15
Darcy Burbage: A Great Session to End MASCC 2025 Annual Meeting
Blog
Jun 30, 2025, 15:49
Aaron Goodman: Transplant and Cell Therapy has Arrived in the State of Nevada
Blog
Jun 30, 2025, 15:34
Sumanta Pal: New On the Edge of Breakthrough Podcast Episode is Out
Blog
Jun 30, 2025, 15:23
Jasmine Kamboj Reflects on Toni Choueiri’s Insights in Empowering Oncologists Podcast Episode
Blog
Jun 30, 2025, 15:15
Small Steps, Big Living: Why What You Don’t Do Matters - Sami Mansfield
Blog
Jun 30, 2025, 15:03
Pratiek Paatil Questions the Increasing Incidence of TP53 Mutations in Cancer Patients
Science
Jun 30, 2025, 15:02
Arndt Vogel: KRAS Variants were Linked to Poor Prognosis in Biliary Tract Cancers
Blog
Jun 30, 2025, 14:52
European Cancer Organisation - Registration is Open for Community 365 Roundtable: Addressing the Challenges of Women and Cancer
Science
Jun 30, 2025, 14:51
Rami Manochakian: MARIPOSA Trial and Latest Developments in the Treatment of EGFR+ NSCLC